| Hans-Günter Meyer-Thompson | Naloxon
USA. Major opioid maker to pay for overdose-antidote development
USA. Major opioid maker to pay for overdose-antidote development
A company whose prescription opioid marketing practices are being blamed for sparking the addiction and overdose crisis says it's helping to fund an effort to make a lower-cost overdose antidote.
OxyContin maker Purdue Pharma announced Wednesday that it's making a $3.4 million grant to Harm Reduction Therapeutics, a Pittsburgh-based nonprofit, to help develop a low-cost naloxone nasal spray. (medicalxpress.com, USA, 05.09.2018)
https://medicalxpress.com/news/2018-09-major-opioid-maker-overdose-antidote.html